204 related articles for article (PubMed ID: 12972847)
1. Defining the need for radiotherapy for lung cancer in the general population: a criterion-based, benchmarking approach.
Barbera L; Zhang-Salomons J; Huang J; Tyldesley S; Mackillop W
Med Care; 2003 Sep; 41(9):1074-85. PubMed ID: 12972847
[TBL] [Abstract][Full Text] [Related]
2. Defining the need for breast cancer radiotherapy in the general population: a criterion-based benchmarking approach.
Kerba M; Miao Q; Zhang-Salomons J; Mackillop W
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):481-9. PubMed ID: 17467249
[TBL] [Abstract][Full Text] [Related]
3. Defining the need for prostate cancer radiotherapy in the general population: a criterion-based benchmarking approach.
Kerba M; Miao Q; Zhang-Salomons J; Mackillop W
Clin Oncol (R Coll Radiol); 2010 Dec; 22(10):801-9. PubMed ID: 20797840
[TBL] [Abstract][Full Text] [Related]
4. Management and outcome of glottic cancer: a population-based comparison between Ontario, Canada and the SEER areas of the United States. Surveillance, Epidemiology and End Results.
Groome PA; Mackillop WJ; Rothwell DM; O'Sullivan B; Irish JC; Hall SF; Warde PR; Holowaty EJ
J Otolaryngol; 2000 Apr; 29(2):67-77. PubMed ID: 10819103
[TBL] [Abstract][Full Text] [Related]
5. Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer.
Hayman JA; Abrahamse PH; Lakhani I; Earle CC; Katz SJ
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1001-7. PubMed ID: 17689029
[TBL] [Abstract][Full Text] [Related]
6. A comparison of evidence-based estimates and empirical benchmarks of the appropriate rate of use of radiation therapy in ontario.
Mackillop WJ; Kong W; Brundage M; Hanna TP; Zhang-Salomons J; McLaughlin PY; Tyldesley S
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1099-107. PubMed ID: 25832700
[TBL] [Abstract][Full Text] [Related]
7. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy patterns of care study in lung carcinoma.
Movsas B; Moughan J; Komaki R; Choy H; Byhardt R; Langer C; Goldberg M; Graham M; Ettinger D; Johnstone D; Abrams R; Munden R; Starkschall G; Owen J
J Clin Oncol; 2003 Dec; 21(24):4553-9. PubMed ID: 14597743
[TBL] [Abstract][Full Text] [Related]
9. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
10. Resources and management strategies for the use of radiotherapy in the treatment of lung cancer in Central and Eastern European countries: results of an International Atomic Energy Agency (IAEA) survey.
Kepka L; Danilova V; Saghatelyan T; Bajcsay A; Utehina O; Stojanovic S; Yalman D; Demiral A; Bondaruk O; Kuddu M; Jeremic B;
Lung Cancer; 2007 May; 56(2):235-45. PubMed ID: 17267070
[TBL] [Abstract][Full Text] [Related]
11. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
12. Temporal trends in the management of potentially resectable lung cancer.
Farjah F; Wood DE; Yanez D; Symons RG; Krishnadasan B; Flum DR
Ann Thorac Surg; 2008 Jun; 85(6):1850-5; discussion 1856. PubMed ID: 18498783
[TBL] [Abstract][Full Text] [Related]
13. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy utilisation in lung cancer in New Zealand: disparities with optimal rates explained.
Stevens G; Stevens W; Purchuri S; Kolbe J; Cox B
N Z Med J; 2009 Nov; 122(1306):43-54. PubMed ID: 20145686
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
Stessin AM; Meyer JE; Sherr DL
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
[TBL] [Abstract][Full Text] [Related]
16. Unexpected long-term survival after low-dose palliative radiotherapy for non-small cell lung cancer.
Mac Manus MP; Matthews JP; Wada M; Wirth A; Worotniuk V; Ball DL
Cancer; 2006 Mar; 106(5):1110-6. PubMed ID: 16432830
[TBL] [Abstract][Full Text] [Related]
17. Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma.
Delaney G; Jacob S; Barton M
Cancer; 2005 Jun; 103(11):2216-27. PubMed ID: 15856428
[TBL] [Abstract][Full Text] [Related]
18. Estimating the need for palliative radiotherapy for non-small cell lung cancer: A criterion-based benchmarking approach.
Jin CJ; Kong W; Mackillop WJ
Radiother Oncol; 2018 Sep; 128(3):541-547. PubMed ID: 29934108
[TBL] [Abstract][Full Text] [Related]
19. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
[TBL] [Abstract][Full Text] [Related]
20. Estimating the Need for Palliative Radiation Therapy: A Benchmarking Approach.
Mackillop WJ; Kong W
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):51-59. PubMed ID: 26700702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
